Skip to main content
Log in

Glucocorticoids and TGF-β1 Synergize in Augmenting Fibroblast Mediated Contraction of Collagen Gels

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

TGF-β plays a central role in the initiation and progression of pulmonary fibrosis. Glucocorticoids are frequently used to treat fibrotic diseases, but beneficial effects are often modest. Both TGF-β and glucocorticoids have been reported to increase fibroblast contraction of native collagen gels, a model of fibrotic tissue remodeling. Therefore, we sought to determine how glucocorticoids interact with TGF-β in this system. In this study, human fetal lung fibroblasts (HFL-1) were pretreated with or without TGF-β for 72 h before they were cast into type I collagen gels. Various concentrations of glucocorticoids (budesonide or hydrocortisone) were added at the time of casting. Gel size was then monitored at different times after gel release. The surrounding media were collected for the assay of prostaglandin E2 (PGE2) and the cell lysates were analyzed for cyclooxygenase (COX) expression by immunoblot. Glucocorticoids alone significantly enhanced fibroblast-mediated contraction of collagen gels (P < 0.01) and dose-dependently inhibited PGE2 release by HFL-1 fibroblasts. TGF-β significantly augmented gel contraction but also induced a 30% increase in PGE2 release and increased the expression of COX-1. Glucocorticoids inhibited TGF-β1 induced-PGE2 release, and enhanced TGF-β augmented gel contraction without significantly affecting TGF-β augmented COX-1 expression. Indomethacin, a COX inhibitor, increased TGF-β augmented gel contraction but had no further effect when added together with glucocorticoids. Thus, glucocorticoids can synergize with TGF-β in augmenting fibroblast mediated collagen gel contraction through the inhibition of PGE2 production. Such interactions between glucocorticoids and TGF-β may account, in part, for the lack of response of fibrotic diseases to glucocorticoids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mio, T., Y. Adachi, D. J. Romberger, R. F. Ertl and S. I. Rennard 1996. Regulation of fibroblast proliferation in three dimensional collagen gel matrix. In Vitro Cell Deve. Biol. 32: 427–433.

    Google Scholar 

  2. Elsdale, T. and J. Bard. 1972. Collagen substrata for studies on cell behavior. J. Cell Biol. 54: 626–637.

    Google Scholar 

  3. Labarca, C. and K. Paigen. 1980. A simple, rapid and sensitive DNA assay procedure. Anal. Biochem. 102: 344–352.

    PubMed  Google Scholar 

  4. Bergman, I. and R. Loxley. 1963. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem. 35: 1961–1965.

    Google Scholar 

  5. Laemmli, U. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680–685.

    PubMed  Google Scholar 

  6. Tomasek, J. J., C. J. Haaksma, R. J. Eddy and M. B. Vaughan. 1992. Fibroblast contraction occurs on release of tension in attached collagen lattices: dependency on an organized actin cytoskeleton and serum. Anat. Rec. 232: 359–368.

    PubMed  Google Scholar 

  7. Skold, C. M., X. Liu, Y. K. Zhu, T. Umino, K. Takigawa, Y. Ohkuni, R. F. Ertl, J. R. Spurzem, D. J. Romberger, R. Brattsand and S. I. Rennard. 1999. Glucocorticoids augment fibroblast mediated contraction of collagen gels by inhibition of endogenous PGE production. Proc. Assn. Am. Phys. 111: 249–258.

    Google Scholar 

  8. Coulomb, B., L. Dubertret, E. Bell and R. Touraine. 1984. The contractility of fibroblasts in a collagen lattice is reduced by corticosteroids. J. Invest. Derm. 82: 341–344.

    PubMed  Google Scholar 

  9. Singer, A. J. and R. A. F. Clark. 1999. Cutaneous wound healing. N. Engl. J. Med. 341: 738–746.

    PubMed  Google Scholar 

  10. Rennard, S. 1997. Pathophysiological mechanisms of COPD. Eur. Respir. Rev. 7: 206–210.

    Google Scholar 

  11. Rennard, S. I. 1999. Inflammation and repair processes in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160: S12–S16.

    PubMed  Google Scholar 

  12. Ehrlich, H. P. and D. J. Wyler. 1983. Fibroblast contraction of collagen lattices in vitro: Inhibition by chronic inflammatory cell mediators. J. Cell Phys. 116: 345–351.

    Google Scholar 

  13. Schalkwijk, C., M. Vervoordeldonk, J. Pfeilschifter, F. Marki and H. Van Den Bosch. 1991. Cytokine-and forskolin-induced syntehsis of group II phosphilipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasone. Biochem. Biophys. Res. Commun. 180: 46–52.

    PubMed  Google Scholar 

  14. Nakano, T., O. O., H. Teraoka and H. Arita. 1990. Glucocorticoids suppress group II phosphilipase A2 production by blocking mRNA synthesis and posttranscriptional expression. J. Biol. Chem. 265: 12745–12748.

    PubMed  Google Scholar 

  15. Goulding, N. J., J. L. Godolphin and P. R. Sharland. 1990. Antiinflammatory lipocortin 1 production by peripheral leucocytes in response to hydrocortisone. Lancet. 335: 1416–1418.

    PubMed  Google Scholar 

  16. Peers, S. H., F. Smillie, A. J. Elderfield and R. J. Flower. 1993. Glucocorticoid and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo. Br. J. Pharmacol. 108: 66–72.

    PubMed  Google Scholar 

  17. Errasfa, M. and F. Russo-Marie. 1989. A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice. Br. J. Pharmacol. 97: 1051–1058.

    PubMed  Google Scholar 

  18. Solito, E., G. Raugei, M. Melli and L. Paretne. 1991. Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated but not undifferentiated U-937 cells. FEBS Lett. 291: 238–244.

    PubMed  Google Scholar 

  19. Liu, X. D., R. Ertl, C. M. Sköld, K. Takigawa, D. J. Romberger, J. R. Spurzem and S. I. Rennard. 1997. TGF-β pretreated human fetal lung fibroblasts possess enhanced ability to contract type I collagen gels. Am. J. Respir. Crit. Care Med. 155: A178.

    Google Scholar 

  20. Ziesche, R., E. Hofbauer, K. Wittmann, V. Petkov and L. H. Block. 1999. A preliminary study of long-term treatment with interferon gramma-1β and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N. Eng. J. Med. 341: 1264–1269.

    Google Scholar 

  21. Burke, C., C. K. Power, A. Norris, A. Condez, B. Schmekel and L. W. Poulter. 1992. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur. Respir. J. 5: 73–79.

    PubMed  Google Scholar 

  22. Trigg, C. J., N. D. Manolitsas, J. Wang, M. A. Calderon, A. McAulay, S. E. Jordan, M. J. Herdman, N. Jhalli, J. M. Duddle, S. A. Hamilton, J. L. Devalia and R. J. Davies. 1994. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am. J. Respir. Crit. Care Med. 150: 17–22.

    PubMed  Google Scholar 

  23. Laiinene, A., A. Altraja, M. Kämpe, M. Linden, I. Virtanen and L. A. Laitinene. 1997. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am. J. Respir. Crit. Care Med. 156: 951–958.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wen, FQ., Sköld, C.M., Liu, XD. et al. Glucocorticoids and TGF-β1 Synergize in Augmenting Fibroblast Mediated Contraction of Collagen Gels. Inflammation 25, 109–117 (2001). https://doi.org/10.1023/A:1007170622699

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007170622699

Navigation